The New York State Psychiatric Institute
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1895-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.nyspi.org
Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 60
- Registration Number
- NCT03169816
- Locations
- 🇺🇸
Substance Treatment and Research Service (STARS), Columbia University, New York, New York, United States
Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol
Phase 2
Terminated
- Conditions
- Opioid-use Disorder
- Interventions
- First Posted Date
- 2017-04-13
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 10
- Registration Number
- NCT03113409
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3
Not Applicable
Completed
- Conditions
- Substance AbuseSubstance Related ProblemSubstance-Related DisordersSubstance DependenceSubstance UseSubstance Use Disorders
- Interventions
- Behavioral: Family CONNECT
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 22
- Registration Number
- NCT03048552
The Cultural Formulation Interview-Engagement Aid
Not Applicable
Completed
- Conditions
- CommunicationAdherence, Patient
- Interventions
- Behavioral: The Cultural Formulation Interview-Engagement AidBehavioral: The Cultural Formulation Interview-Engagement Aid (Revised)Behavioral: Treatment as usual
- First Posted Date
- 2017-02-06
- Last Posted Date
- 2019-01-25
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 45
- Registration Number
- NCT03044145
- Locations
- 🇺🇸
Flushing Hospital Medical Center, Flushing, New York, United States
Pilot Study of the Impact of Exercise on Hippocampal Function
Not Applicable
Completed
- Conditions
- Anxiety
- Interventions
- Behavioral: High Intensity Interval Exercise
- First Posted Date
- 2017-01-30
- Last Posted Date
- 2019-03-27
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 14
- Registration Number
- NCT03036371
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Are Bright Lights and Regulated Sleep Effective Treatment for Depression?
Not Applicable
Completed
- Conditions
- Sleep DeprivationSleep Phase Rhythm Disturbance
- Interventions
- Behavioral: Morning Light TherapyBehavioral: Assigned Sleep TimesDevice: Goggles
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 44
- Registration Number
- NCT03010488
- Locations
- 🇺🇸
Depression Evaluation Service - New York State Psychiatric Institute, New York, New York, United States
Clinical Trial of AVL-3288 in Schizophrenia Patients
Phase 1
Completed
- Conditions
- SchizophreniaSchizoaffective Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-12-01
- Last Posted Date
- 2019-01-22
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 24
- Registration Number
- NCT02978599
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Neuroimaging in Patients Undergoing TMS for Depression
Not Applicable
Completed
- Conditions
- Treatment Resistant Depression
- Interventions
- Device: transcranial magnetic stimulation
- First Posted Date
- 2016-11-28
- Last Posted Date
- 2020-10-23
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 33
- Registration Number
- NCT02974296
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Facilitating the Behavioral Treatment of Cannabis Use Disorder
- First Posted Date
- 2016-10-27
- Last Posted Date
- 2020-02-11
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 8
- Registration Number
- NCT02946489
- Locations
- 🇺🇸
NYSPI, New York, New York, United States
Flavanol Augmentation for Antidepressant Non-Responsive Late Life Depression
Not Applicable
Terminated
- Conditions
- DepressionMajor Depressive Disorder
- Interventions
- Dietary Supplement: CocoaViaOther: Placebo
- First Posted Date
- 2016-10-24
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 6
- Registration Number
- NCT02943096
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath